The Federal Trade Commission is launching a probe into recent shortages of chemotherapies and other drugs, examining the role played by companies that help buy and distribute the bulk of medicines sold to U.S. hospitals.
The inquiry shines a spotlight on a little-noticed corner of the drug supply chain—but one that can have an outsize impact on stores of critical medicines.
Top 10 Unique Homemade Gift Ideas for the Eco-Conscious in 2026
The landscape of gift-giving in 2026 has shifted from mass-market consumerism to “regenerative gifting”—presents that not only minimize harm but
